What is pembrolizumab (Keytruda) and is it used for Lymphoma

LymphomaMay 15, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
Built by OpenCancer’s team of physician-scientists and cancer survivors.
Last updated May 15, 2026. Informational only — not a substitute for your oncology team.

Pembrolizumab (Keytruda) and Lymphoma Treatment

What is Pembrolizumab?

Pembrolizumab is a type of immunotherapy drug that works by "releasing the brakes" on your immune system. Here's how it functions:

The Basic Mechanism: Your immune system has natural "off switches" that prevent it from attacking your own cells. Cancer cells exploit these switches to hide from your immune system. Pembrolizumab blocks one of these off switches (called PD-1), allowing your T cells (a type of white blood cell) to recognize and attack cancer cells more effectively.

Use in Lymphoma

Yes, pembrolizumab is used for certain types of lymphoma, though not all lymphoma types. According to the NCCN Guidelines, pembrolizumab has FDA approval for specific lymphoma subtypes, particularly:

Hodgkin lymphoma (both classical and primary mediastinal types)
Certain non-Hodgkin lymphomas in specific situations, particularly when other treatments haven't worked

The drug is typically considered for patients with relapsed or refractory disease (meaning the cancer has returned or didn't respond to initial treatment).

Important Context for Your Situation

Since you have lymphoma, whether pembrolizumab is appropriate for you depends on several factors your oncology team will evaluate:

Your specific lymphoma subtype (Hodgkin vs. non-Hodgkin, and which specific type)
Your disease stage and whether it's newly diagnosed or relapsed
Prior treatments you've received
Biomarker testing results (such as PD-L1 expression)
Your overall health and ability to tolerate immunotherapy

Questions to Ask Your Oncologist

Is pembrolizumab an option for my specific type of lymphoma?
Have I had biomarker testing (like PD-L1) that would help determine if this drug might work for me?
What are the potential side effects I should watch for?
How would this compare to other treatment options available for my situation?
If pembrolizumab is recommended, what's the treatment schedule and how long would I receive it?

Important Note

Immunotherapy drugs like pembrolizumab can have significant side effects because they activate your immune system. These can include fatigue, skin reactions, and in some cases, more serious autoimmune-type reactions. Your care team will monitor you closely during treatment.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →